droxy-PP-Me is a potent and specific CBR1 inhibitor with an IC50 of 759 nM. droxy-PP-Me inhibits serum-withdrawal-induced apoptosis. droxy-PP-Me increases As2O3-induced apoptotic cell death compared with As2O3 alone.
References:
[1]. Tanaka M, et al. An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol. 2005 May;3(5):e128.
[2]. Jang M, et al. Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide. Cancer Res. 2012 Aug 15;72(16):4214-24.